Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share Capital (Details) - Schedule of options granted outstanding and exercise prices

v3.22.2
Share Capital (Details) - Schedule of options granted outstanding and exercise prices - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Schedule of options granted outstanding and exercise prices [Abstract]    
Number of options, Outstanding at beginning 16,319,786 1,814,381
Weighted average exercise price, Outstanding at beginning $ 0.12 $ 0.58
Number of options, Outstanding at ending 18,323,222 16,319,786
Weighted average exercise price, Outstanding at ending $ 0.12 $ 0.12
Weighted average remaining contractual life (years), Outstanding at ending 4 years 11 months 19 days 5 years 9 months 14 days
Aggregate intrinsic-value, Outstanding at ending $ 342,452 $ 2,581,719
Number of options, Exercisable 11,332,153 5,913,492
Weighted average exercise price, Exercisable $ 0.08 $ 0.14
Weighted average remaining contractual life (years), Exercisable 4 years 8 months 4 days 5 years 4 months 24 days
Aggregate intrinsic-value, Exercisable $ 233,086 $ 844,712
Number of options, Granted 2,003,436 14,678,734
Weighted average exercise price, Granted $ 0.17 $ 0.07
Number of options, Options forfeited   (173,329)
Weighted average exercise price, Options forfeited   $ 0.74